Causation and Prevention of Solely Estrogen- Induced Oncogenesis: Similarities to Human Ductal Breast Cancer

  • Jonathan J. Li
  • Sara Antonia Li
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 532)


Estrogens are intimately involved in the causation of some of the most prevalent cancers afflicting women, particularly, breast, endometrial, cervico-vaginal, and possibly ovarian. Therefore, it has become particularly pertinent to elucidate the molecular changes and mechanisms whereby estrogens elicit their oncogenic actions so that better prevention strategies can be developed. The estrogen-induced Syrian hamster tumors of the kidney have emerged as one of the most intensively studied in-vivo models in solely estrogen-induced oncogenesis. An advantage of this model is that the tumors occur in the absence of any intervening morphologic changes, but rather they are the result of the continuous progression of a subset of interstitial stem cells in the kidney leading to tumor formation. Evidence is presented that the origin of these tumors is derived from ectopic “uterine” stem cells, which are responsive to estrogenic hormones. The other animal tumor model studied is the highly sensitive estrogen-induced mammary tumors of female ACI rats. Their steroid receptor and other gene alterations have been delineated. Importantly, a crucial early event in this solely estrogen-induced oncogenic process, common to both animal tumor models, is the overexpression and amplification ofc-mycand its protein product. Chromosomal instability, in both early and large well-established frank tumors, is another important characteristic found during early E-induced oncogenesis. These features have been shown to be characteristic of human ductal carcinomasin-situand in primary invasive ductal breast carcinomas. The molecular alterations seen are considered crucial in eliciting estrogen-induced oncogenesis and have established for the first time a direct causal link between estrogen and the induction of chromosomal instability and aneuploidy in these estrogen-associated neoplasms.


Breast Cancer Mammary Gland Syrian Hamster Mammary Gland Tumor Tamoxifen Citrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cancer statistics.Cancer J. Clin. 49:1–156 (1999).Google Scholar
  2. 2.
    Li, C.I., Weiss, N.S., Stanford, J.L., Daling J.R. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88:2570–2577 (2000).PubMedCrossRefGoogle Scholar
  3. 3.
    King, M.C., Rowell, S., Love, S.M. Inherited breast cancer and ovarian cancer. What are the choices? J. Am. Med. Assoc. 269:175–180 (1993).CrossRefGoogle Scholar
  4. 4.
    Gammon, M.D., Santella, R.M., Neugut, A.I., Eng, S.M., Teitelbaum, S.L., Paykin, A., Levin, B., Terry, M.B., Young, T.L., Wang, L.W., et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidem. Biomarkers & Prevent. 11:677–685 (2002).Google Scholar
  5. 5.
    Gammon, M.D., Wolff, M.S., Neugut, A.I., Eng, S.M., Teitelbaum, S.L., Britton, J.A., Terry, M.B., Levin, B., Sellman, S.D. Kabat, G.C., et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidem. Biomarkers & Prevent. 11:686–697 (2002).Google Scholar
  6. 6.
    Li, J.J., and S.A. Li. Breast cancer: Evidence for xenoestrogen involvement in altering its incidence and risk. In: Natural and Anthropogenic Environmental Oestrogens: The Scientific Basis for Risk Assessment. J. Pure & Appl. Chem. (IUPAC), 70:1713–1723 (1998).CrossRefGoogle Scholar
  7. 7.
    Fisher B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Nat. Cancer Inst. 90:1371–1388 (1998).Google Scholar
  8. 8.
    Li, S.A., Xue, Y., Xie, Q., Li, C.I., Li, J.J. Serum and tissue levels of estradiol during estrogen-induced renal tumorigenesis in the Syrian hamster. J. Steroid Biochem. Molec. Biol. 48:283–286 (1994).Google Scholar
  9. 9.
    Li, S.A., Weroha, S.J., Tawfik, O., Li, J.J. Prevention of solely estrogen-induced mammary tumors by Tamoxifen: Evidence for estrogen receptor mediation. J. Endocrinol. 175:297–305 (2002).PubMedCrossRefGoogle Scholar
  10. 10.
    Kirkman, H., Robbins, M. Histogenesis of estrogen-induced renal tumors in golden hamster. Anat. Res. 121:323 (1955).Google Scholar
  11. 11.
    Donten, W., Eder, M. Histogenese and biologische Verhaltenweise hormonell augeloster Geschwulste Beitr path. Anat. 120:270 (1959).Google Scholar
  12. 12.
    Llombart-Bosch, A., Peydro, A. Morphological, histochemical and ultrastructural observations of diethylstilbestrol-induced kidney tumors in the Syrian golden hamster. Europ. J. Cancer 11:403–412 (1975).Google Scholar
  13. 13.
    Gonzalez, A., Oberley, T.D., Li, J.J. Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: Probable cell of origin. Cancer Res. 49:1020–1028 (1989).PubMedGoogle Scholar
  14. 14.
    Oberley, T.D., Gonzalez, A., Lauchner, L.J., Oberley, L.W., Li, J.J. Characterization of early lesions in estrogen-induced renal tumors in the Syrian hamster. Cancer Res. 51:1922–1929 (1991).PubMedGoogle Scholar
  15. 15.
    Li, J.J., Weroha, S.J., Davis, M.F., Hou, X., Tawfik, O., Li, S.A. Estrogen and progesterone receptors in renomedullary interstitial cells during Syrian hamster estrogen-induced tumorigenesis: Evidence for receptor-mediated oncogenesis. Endocrinology 142:4006–4014 (2001).PubMedCrossRefGoogle Scholar
  16. 16.
    Pelletier, G., Labrie, C., Labrie, F. Localization of oestrogen receptor, oestrogen receptor,, and androgen receptors in the rat reproductive organs. J. Endocrinology 165:359–370 (2000).CrossRefGoogle Scholar
  17. 17.
    Li, J.J., Cuthbertson, T.L., Li, S.A. Inhibition of estrogen carcinogenesis in the Syrian golden hamster kidney by antiestrogens. J. Nat. Cancer Inst. 64:795–800 (1980).PubMedGoogle Scholar
  18. 18.
    Kirkman H. Estrogen-induced tumors of the kidney in Syrian hamsters. J. Natl. Cancer Inst. Monogr. 1:159 (1959).Google Scholar
  19. 19.
    Nandi, S., Guzman, R.C., Yang, J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Nat. Acad. Sci. USA 92:3650–3657 (1995).CrossRefGoogle Scholar
  20. 20.
    Hou, X. Li, J.J., Chen, W.B., Li, S.A. Estrogen-induced protooncogene and suppressor gene expression in the hamster kidney: Significance for estrogen carcinogenesis. Cancer Res. 56:2616–2620 (1996).PubMedGoogle Scholar
  21. 21.
    Li, J.J., Papa, D., Davis, M.F., Weroha, S.J., Aldaz, M., El-Bayoumy, K, Ballenger, J., Tawfik, O., Li, S.A. Ploidy differences between hormone-and chemical carcinogen-induced mammary neoplasms: Relations to human breast cancer. Molec. Carcinogen. 33:56–65 (2002).CrossRefGoogle Scholar
  22. 22.
    Chepko, G., Smith, G.H. Mammary epithelial stem cells: Our current understanding. J. Mammary Gland Biol. Neoplasia 4:35–52 (1999).PubMedCrossRefGoogle Scholar
  23. 23.
    Li, J.J., Hou, X., Bentel, J.M., Yazlovitskaya, E.M., Li, S.A. Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: Some unique properties of a synthetic estrogen. Carcinogenesis 19:471–477 (1998).PubMedCrossRefGoogle Scholar
  24. 24.
    Li, J.J., Weroha, S.J., Cansler, M, Li, S.A. Estrogen receptor-mediated genomic instability in the Syrian hamster kidney: A critical event in hormonal carcinogenesis. In: Hormonal Carcinogenesis III (Eds. Li, J.J., Daling, J.R., Li, S.A.), Springer-Verlag, New York, pp. 149–157 (2000).Google Scholar
  25. 25.
    Li, J.J., Papa, D., Li, S.A. Ectopic uterine stem cell tumors in the hamster kidney: A unique model for estrogen-induced oncogenesis. Minerva Endocrinol., in press (2003).Google Scholar
  26. 26.
    Li, J.J., Hou, X., Banerjee, S.K., Liao, D.J., Maggouta, F., Norrris, J.S., Li, S.A. Overexpression and amplification ofc-mycin the Syrian hamster kidney during estrogen carcinogenesis: A probable critical role in neoplastic transformation. Cancer Res. 59:2340–2346 (1999).PubMedGoogle Scholar
  27. 27.
    Felsher D.W., Bishop, J.M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Nat. Acad. Sci. USA 96:3940–3944 (1999).PubMedCrossRefGoogle Scholar
  28. 28.
    Eilers, M., Picard, D., Yammamoto, K.R., Bishop, J.M. Chimaeras of MYC oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66–68 (1989).PubMedCrossRefGoogle Scholar
  29. 29.
    Taylor, C., Jalava, A., Mai, S. c-Myc dependent initiation of genomic instability during neoplastic transformation. Curr. Top. Microbiol. Immunol. 224:201–207 (1997).PubMedCrossRefGoogle Scholar
  30. 30.
    Yiu, X.Y., Grove L, Datta, N.S., Long, M.W., Prochownik, E.V. C-Myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18:1177–1184 (1999).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Jonathan J. Li
    • 1
  • Sara Antonia Li
    • 1
  1. 1.Division of Etiology & Prevention of Hormonal Cancers, and Department of Pharmacology, Toxicology and TherapeuticsUniversity of Kansas Medical Center Kansas City

Personalised recommendations